Investments in German small and mid caps are making a comeback
Citywire Award for Lupus alpha Smaller German Champions under Portfolio Manager Björn Glück
After years of underperformance against large caps and especially against US mega caps, investors’ interest in German small and mid caps is returning. Strong fundamentals with favourable valuations have been pointing to their enormous performance potential for some time. The massive EUR 1.5 trillion spending programs on infrastructure and defence are providing new tailwinds for SDAX and MDAX companies.
While the fiscal consequences of the planned investment fund are sometimes viewed critically, the effect on sales and profits of German small and mid caps is clearly positive. Expected earnings growth
e.g. for the MDAX (2026 +22.28%) is almost twice as high as the DAX large caps (+14.23%).
“We are currently seeing a fundamental revaluation of the German market,” Dr. Götz Albert, Partner and CIO at Lupus alpha, describes the current market situation. “German companies are benefiting from massive government investment programmes for infrastructure and defence. These not only create short-term stimulus, they are structurally changing the growth prospects of many industries through second-round effects.”
This is reflected in the double-digit index performance of SDAX (approx. 21.5%) and MDAX (approx. 19.6%) from early January to late May. Lupus alpha Smaller German Champions (ISIN: LU0129233507) posted a performance of 21.6% over the same period. Since its inception in 2002, the Fund has outperformed its benchmark (half of SDAX and MDAX) by more than 240 basis points per annum (as at 30/05/2025).
“The potential for recovery remains considerable, as many German small and mid caps, despite their excellent fundamentals, are still trading well below their historical valuation levels,” explains Dr Götz Albert on the current market dynamics. “As an active manager, we can specifically seek out the less obvious winners in the second tier." This presents a significant opportunity to identify the stocks with the highest potential before they are recognised by the wider market."
Björn Glück, Portfolio Manager of the Lupus alpha Smaller German Champions, sees significant opportunities particularly in technology stocks: “The infrastructure and investment programmes are particularly beneficial to innovative companies with a focus on high technology, such as robotics, sensors and ultrasound. This includes civilian applications as well as defence. In these areas, specialised companies from MDAX and SDAX often dominate, which impress with their innovative solutions.”
Since the beginning of the year, the Lupus alpha Smaller German Champions has recorded net new inflows of more than EUR 30 million. This development confirms the new interest in German small and mid caps.
At the 2025 Citywire Germany Portfolio Manager & Group Awards, Lupus alpha was named the best fund company in the “Aktien – Deutschland Small & Mid Caps” category. The decisive factor for this success is the consistently impressive performance of Björn Glück, who has been in charge of the Lupus alpha Smaller German Champions since 2012.
Download press release
Download portrait of Dr. Götz Albert
Download portrait of Björn Glück
About Lupus alpha: As an independent, owner-operated asset management company, Lupus alpha has been synonymous with innovative, specialised investment solutions for 25 years. As one of Germany’s European small and mid-cap pioneers, Lupus alpha is one of the leading providers of volatility strategies as well as collateralised loan obligations (CLOs). The specialist product range is rounded off by global convertible strategies and risk overlay solutions for institutional portfolios. The Company manages a volume of more than EUR 16 billion for institutional and wholesale investors. For further information, visit www.lupusalpha.fr.
Disclaimer
This fund information is provided for general information purposes only. This information is not designed to replace the investor‘s own market research, financial analysis, nor any other legal, tax or financial information or advice. The information presented does not constitute in any manner a solicitation activity, an invitation to buy or sell, nor an ancillary investment service such as investment research or financial analysis within the meaning of Section B(5) of Annex II, nor does it qualify as investment advice within the meaning of Section A(5) of Annex I of MiFID II (as it does not amount to an objective and independent explanation of a recommendation within the meaning of article 36,1.a) of the Delegated Regulation (EU) 2017/565 of 25 April 2016) and should not be treated by recipients as such. It does not contain any key information enabling to make important economic decisions and may differ from information and estimates provided by other sources or market participants. We accept no liability for the accuracy, completeness or topicality of this information. All statements are based on our assessment of the present legal and tax situation. All opinions reflect the current views of the portfolio manager and can be changed without prior notice. Full details of our funds and their licenses of distribution can be found in the relevant current sales prospectus and, where appropriate, Key Information Document, supplemented by the latest audited annual report and/or half-year report. The relevant sales prospectus and Key Information Documents prepared in German are the sole legally-binding basis for the purchase of funds managed by Lupus alpha Investment GmbH. You can obtain these documents free of charge from Lupus alpha Investment GmbH, P.O. Box 1112 62, 60047 Frankfurt am Main, Germany, upon request by calling +49 69 365058-7000, by e-mailing info@lupusalpha.de or via our website www.lupusalpha.de. If funds are licensed for distribution in Austria the respective sales prospectus, Key Information Document and the latest audited annual report or half-year report are available from the Austrian paying and information agent UniCredit Bank Austria AG based in Rothschildplatz 1, 1020 Vienna, Austria. Fund units can be obtained from banks, savings banks and independent financial advisors.
This document is directed at professional investors only. Therefore, neither this document nor the information made available thereon shall be construed as a distribution in or from France to any person other than professional.
Neither this fund information nor its contents or a copy thereof may be amended, reproduced or transmitted to third parties in any way without the prior written consent of Lupus alpha Investment GmbH. By accepting this document, you declare your consent to comply with the aforementioned provisions. Subject to change without notice.
Unless otherwise specified, all indicated performance data show the gross performance (BVI method): The gross performance considers all costs incurred at Fund level (e. g. management fee) and assumes reinvestment of any distributions. Costs incurred at customer level such as sales charge and securities account costs are not included. Please note: Past performance is not a reliable indicator the future performance.
Lupus alpha Investment GmbH
Speicherstraße 49–51
D-60327 Frankfurt am Main
